Cancer Studies and Molecular Medicine

Open journal

ISSN 2377-1518

Systematic Review

2022 Nov

Moises Cukier*, José M. Cabada-Lee, Jorge D. Méndez-Ríos, Rafaél Arauz, Erik Arauz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz, Olivia El Achtar, Kenia Franco, Julissa Lobardo-Quezada, Yong Loo, Melisa I. Menéndez, Gaspar Pérez-Jiménez, José Pinto-Llerena, Lizka Richards-Cantoral, Mauricio Rodríguez-Bravo, Maylin Ruiz, Karen E. Suñé, Ignacio Veliz and Ruth Vergara-Vásquez

Opinion

2022 Oct

Daniel Gandia* and Cecilia Suarez

review

2020 Sep

Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu

Opinion

2020 May

Daniel Gandia* and Cecilia Suárez

Special Editions

About the Journal

Cancer is defined as the uncontrolled growth or division of cells that results in benign (stationary tumours) or malignant (invading/spreading to nearby parts of the body) tumours.

Cancer, which is the most researched topic in the scientific world due to its unstable treatment methods, is one of the leading causes of death today.

Molecular medicine, on the other hand, is a broad field that incorporates physical, chemical, biological, and medical techniques to depict various molecular structures and their mechanisms. This topic has demonstrated its significance in the field of cancer by amplifying molecular-level dysfunctionalities during the cell cycle.

Therefore, advanced diagnostic techniques for cancer management and treatment have been developed to analyse and monitor the root cause of molecular-level malfunction.
As result, scientists were able to identify and comprehend the factors that contribute to tumour development at the cell cycle level, and they were able to devise and implement controlled measures to prevent cancer.
However, Openventio’s open journal aims to disseminate detailed information about cancer research, prevention and treatment to the scientific community for its benefit.

editor-in-chief

Pradeep Garg, PhD

Center for Molecular Imaging and Therapy (CMIT) — Shreveport

Associate editors

Jennifer Sims-Mourtada, PhD

Center for Translational Cancer Research, Helen F. Graham Cancer Center

editors

Unnati M. Pandya, PhD

Discovery Biology, Exo Therapeutics, Inc.

Masahiko Tanabe, MD, PhD

Department of Breast and Endocrine Surgery, The University of Tokyo Hospital

Francis V. James, MD

Department of Radiation Oncology, Regional Cancer Centre

Keechilat Pavithran, DM, MD

Department of Medical Oncology and Hematology, Amrita Vishwa Vidyapeetham

Jian Pan, PhD

Department of Hematology and Oncology, Childrens Hospital of Soochow University

Sajeed A. Rahuman, DM(RT), MD(RT)

Department of Radiation Oncology, Regional Cancer Centre

Khalid Al-Nedawi, PhD

Department of Medical Sciences, McMaster University

Ramachandran Murali, PhD

Department of Biomedical Sciences, Cedars-Sinai Medical Center

Li Chen, PhD

Department of Biostatistics, University of Kentucky

Daniel D. Taub, PhD

Washington DC VA Medical Center

Alexandros Charalabopoulos, MD, PhD

National & Kapodistrian University of Athens

Gokul Das, PhD

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute

Shreya Kanodia, PhD

Department of Biomedical Sciences, MD Anderson Cancer Center

Young K. Chae, MD, MPH, MBA

Feinberg School of Medicine, Northwestern University

Sun-Young Kong, MD, PhD

Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy

Saeed Sadeghi, MD

David Geffen School of Medicine at UCLA

Chatchawin Assanasen, MD

Division of Hematology-Oncology at UT Health San Antonio

Myriam N. Bouchlaka, PhD

Immuno-Oncology / Pharmacology at OncoResponse Inc.

Frank S. Lieberman, MD

Department of Neurology, University of Pittsburgh School of Medicine

Walter A. Hall, MD, MBA

Norton College of Medicine, SUNY Upstate Medical University

reviewers

Necy S. Juat, MD

National Kidney and Transplant Institute, Philippines

Namrata Jayanth, PhD

Bristol Myres Squibb Research Centre, India

Vaishnavi Raja, PhD

Karmanos Cancer Institute, USA

Astha Malik, PhD

Cincinnati Children’s Hospital Medical Center, USA

Poorva Sandlesh, PhD

University of Pennsylvania, USA

Jeanette Reece, PhD, MPH

University of Melbourne, Australia

Asha Eapen, PhD

University of Illinois, USA

Pavan Rajanahalli, PhD

University of Tampa, USA

Oorvashi R. Puli, PhD

University of Dayton, Australia

Shubha Ghosh, PhD

University of California Los Angeles, USA

Yan P. Yu, MD, PhD

University of Pittsburgh, USA

Zhong Liu, PhD

NovaRock Biotherapeutics Ltd, USA

Karel Petrak, MSc, DPhil

NangioTx, Inc, USA

QIN LI, MD

University of Texas, USA

Jennifer L. Bishop, PhD

The University of British Columbia, Canada

James J. Yu, PhD

Harvard Medical School, USA

Supriya Sen, PhD

University of California Los Angeles, USA

Tao Wang, PhD

UT Southwestern Medical Center, USA

Tsai Ming-Ming, PhD

Chang-Gung University of Science and Technology, Taiwan

Feedback Corner

University of Ibadan - CSMMOJ

5/5

Writing a manuscript is one thing, getting a good publisher/Journal is another thing entirely. I appreciate Cancer Studies and Molecular Medicine for finding my article worthy of publishing. Perfect review process and good communication with authors.

The Neurofibromatosis Institute - CSMMOJ

5/5

NF1 is an important disease, respecting the huge numbers of patients and the insights that the disorder and the gene have for other human situations. This disorder has been my focus for 48 years. I was pleased to share such thoughts through Cancer Studies & Molecular Medicine – Open Journal.

Clinical Oncologist - CSMMOJ

5/5

Cancer Studies and Molecular Medicine – Open Journal is an eye-opener to publish with. The reviewers are highly qualified and their comments were accepted by me in order to organize a better structure and add something more in the paper. Happy to have my first paper in this journal.

Broomfield Hospital – CSMMOJ

5/5

Having published my research with Openventio I can without any doubt state that their professionalism is of a high standard as their Journals continuously try to make the academic world better with benefit to both researchers and patients.

Feedback Profile Pic

Regional Oesophagogastric Cancer Centre – CSMMOJ

5/5

Very satisfied with end result.

connect with us

Indexed in